Laparoscopic biliopancreatic diversion with duodenal switch.
Preliminary results demonstrate the feasibility and safety of laparoscopic biliopancreatic diversion with duodenal switch, knowing that the superobese patient carries a higher risk than the normal population or the regular obese patient. Future studies with larger numbers of patients should be able to demonstrate the effectiveness this procedure in reducing weight and comorbidities such as hyperlipidemia, hypertension, sleep apnea, and diabetes mellitus, an effectiveness of that has been proven in an open approach. There is currently poor evidence regarding this effective due to small case series and early follow-up. Further research is needed to examine long-term efficacy, with a high priority given to randomized controlled trials.
Gagner
Michel
M
Department of Surgery, New York Presbyterian Hospital, Joan and Stanford I. Weill Medical College of Cornell University, 525 East 68th Street, New York, NY 10021, USA. mig2016@med.cornell.edu
Matteotti
Ronald
R
D015904:Biliopancreatic Diversion / Q000379:methods*; D004386:Duodenum / Q000601:surgery*; D006801:Humans; D010535:Laparoscopy; D009767:Obesity, Morbid / Q000601:surgery*; D011183:Postoperative Complications; D012086:Reoperation